Discovering a novel therapeutic candidate is a lengthy endeavor. Early steps may include developing a biochemical assay and performing a high-throughput screen to generate leads. Most biochemical assays rely on labels as readouts for enzyme activity. However, these assays suffer from high rates of false-positive hits, leading to questions surrounding the data which can further delay an already long process.
Learn how SAMDI Tech’s label-free solutions helped accelerate a drug discovery program by delivering high-quality, decision-making data ahead of schedule.